CLOXACILLINE STRAGEN 500 mg, powder for solution for injection 10 bottles of 10 ml
Active ingredients: Cloxacillin, Cloxacillin sodium
Commercialized according to BDPMDispensing in France: Prescription only
Powder for solution for injection10 bottles of 10 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- CLOXACILLINE STRAGEN 500 mg, poudre pour solution injectable
- Pharmaceutical form
- poudre pour solution injectable
- Route of administration
- intraveineuse
- Presentation description
- 10 flacon(s) en verre de 10 ml
- Marketing authorisation holder
- STRAGEN-FRANCE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 6 Mar 2023
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
67705206CIP75507328CIP133400955073284Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CLOXACILLINE SODIQUEpoudre | — | SA |
| CLOXACILLINEpoudre | 500 mg · un flacon | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.